Welcome to the Fuel Matters Blog

A resource to help you buy and manage fuel better

vaccination


COVID-19 Vaccine?

By: Ryan Wolfe / Posted on: August 11, 2020

With the global COVID-19 case count reaching 20 million, Russia has approved a vaccine for the disease. There is, however, suspicion around the approval since the trials have yet to conclude the Phase 3 testing. To solidify the vaccine approval, Russian President Vladimir Putin, stated the vaccine is working “effectively enough”- far too vague for most medical professionals throughout the world. What does “effectively enough” constitute? With the vaccination trials being rushed already through the world, how many corners are being cut by the nations at the head of the vaccination development? Like many questions that hint toward political gains and propaganda, we may never truly know the answer to how many corners are being cut on a vaccination approval that could indeed affect the entire globe for better or worse.

Read More

COVID-19 vaccine trials

By: Ryan Wolfe / Posted on: July 15, 2020

To combat COVID-19, Moderna launched a Phase 1 study consisting of 45 participants in an effort to create a vaccine on an expedited timeline. March 16th was the start of the Phase 1 testing. The initial group of 45 people were divided into groups of 15 individuals.   Each grouping received 2 doses of treatment, but each group received a different dosage of the proposed vaccine (25, 100, or 250 microgram dosages). The subjects who received both doses, showed higher levels of virus-defeating antibodies when compared to individuals who had recovered from the coronavirus. The majority of participants who received both dosages did report adverse reactions, as to be expected during the trials.

Read More

Is America ready?

By: Pam Corn / Posted on: April 27, 2020

As we move into week six of social distancing and stay-at-home orders throughout the country, many states are preparing to lift restrictions beginning this week. CNN recently conducted an interview with Bill Gates, the founder of Microsoft. His foundation has studied  pandemics for years and is now involved with the fight against COVID-19. Gates told CNN during his interview that the country can begin to lift restrictions safely if they have the capacity to aggressively test for and trace new cases of the virus.

Read More

Fighting back against COVID-19

By: Pam Corn / Posted on: April 3, 2020

Yesterday afternoon the University of Pittsburgh School of Medicine made a new discovery in the fight against the COVID-19 virus with a possible vaccination they hope can be rolled out sometime this year.

Read More

COVID-19 Clinical Trial Development

By: Ryan Wolfe / Posted on: March 24, 2020

Last week, President Trump, announced the COVID-19 treatments and vaccines are on a “fast track” for development.  But what does that mean?  What is a typical timeline for development and what are the steps that needs followed in order to produce a successful vaccination or treatment?

Read More

Guttman Energy Daily Market Update Disclaimer – The information contained in this market update is derived from sources believed to be reliable; however this update could include technical inaccuracies or typographical errors and Guttman Energy does not guarantee the accuracy, completeness or reliability of this update. FURTHERMORE, THIS UPDATE IS PROVIDED "AS IS," WHERE IS, WITH ALL FAULTS AND WITHOUT ANY WARRANTY OR CONDITION OF ANY KIND, EXPRESS, IMPLIED OR STATUTORY. GUTTMAN ENERGY ALSO SPECIFICALLY DISCLAIMS ALL EXPRESS AND IMPLIED WARRANTIES. YOU USE THIS UPDATE AT YOUR SOLE RISK. This update and any view or comment expressed herein are provided for informational purposes only and should not be interpreted in any way as recommendation or inducement to buy or sell products, commodity futures or options contracts.

Subscribe to our blog

Price Feed

Stay up-to-date on current fuel prices and market trends with our NYMEX price feed (15 minute delay to the live market).

© 2018 Market data provided and hosted by Barchart Market Data Solutions. Fundamental company data provided by Morningstar and Zacks Investment Research. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.

Categories

RSS FEED

feed-icon-28x28.png
Contact Us